STRATA CRITICAL MEDICAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
STRATA CRITICAL MEDICAL, INC. (SRTA) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $33.52 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-04
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $33.52M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $71.00K.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $24.21M; Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed $1.53M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.95M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2026-06-30 | $33.52M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $71.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $24.21M 10-Q · filed 2026-08-04 | $1.53M 10-K · filed 2026-03-03 |
| 2025-09-30 | $2.95M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.98M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $3.06M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $5.81M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $2.69M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.39M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.48M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $4.96M 10-K · filed 2026-03-03 | |
| 2023-09-30 | $3.26M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $8.98M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $6.52M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $7.08M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $9.07M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $9.49M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $28.76M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $31.31M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $42.22M 8-K · filed 2023-01-10 | |
| 2021-06-30 | $38.80M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $37.62M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $36.77M 10-Q · filed 2021-05-24 | |
| 2020-09-30 | $0.00 10-K · filed 2021-12-20 | |
| 2019-12-31 | $16.12M 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |